全球神经修復和再生市场规模、份额、成长分析（按类型、按应用） - 产业预测，2024-2031 年

Global Nerve Repair and Regeneration Market Size, Share, Growth Analysis, By Type(Neurostimulation and Neuromodulation Devices, and Biomaterials), By Application(Peripheral Nerve Injury, Epilepsy) - Industry Forecast 2024-2031

出版日期: 2024年04月01日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球神经修復和再生市场规模为82亿美元，从2023年的92亿美元增长到2031年的230.5亿美元，预测期内（2024-2031年）复合年增长率为12.17%。为美元。

全球神经系统疾病的盛行率不断上升，如帕金森氏症、阿兹海默症和各种中枢神经系统（CNS）疾病，推动了全球市场的上升趋势。受影响人数的迅速增加推动了对有效治疗方案的需求不断增长。医疗领域的主要企业正在积极努力加强产品平臺，以满足不断增长的需求，并推动旨在提高神经系统疾病治疗有效性的技术进步。相信这些措施将大大促进市场拓展。此外，各种中枢神经系统疾病治疗方案的激增正在扩大市场格局。特别是，使用工程神经移植物的治疗方法在恢復患有上肢神经病变的患者的运动和感觉神经功能方面显示出有希望的结果。在美国手外科学会年会上发表的一项研究显示，接受某些神经移植治疗的患者中，75% 的患者运动功能恢復，85% 的感觉恢復。。此外，大众对神经系统疾病的认识不断提高，再加上环境影响、生活方式选择、遗传、营养和身体伤害等因素，人们对这些疾病有了更好的了解。这种意识的提高极大地促进了对神经修復和再生解决方案不断增长的需求。

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东/非洲
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2021年）
主要市场参与者所采取的策略
关键成功策略
近期市集活动
主要企业市场占有率（2021年）

主要企业简介

美敦力（美国）
波士顿科学公司（美国）
雅培实验室（美国）
史赛克公司（美国）
AxoGen, Inc.（美国）
Integra LifeSciences Holdings Corporation（美国）
百特国际公司（美国）
Nevro 公司（美国）
LivaNova PLC（英国）
Cyberonics Inc.（美国）
Orthofix 医疗公司（美国）
Polyganics（荷兰）
Nuvectra 公司（美国）
Polyganics BV（荷兰）
BioTime 公司（美国）
Collagen Matrix, Inc.（美国）
Synovis Micro Companies Alliance, Inc.（美国）
StimGuard LLC（美国）
Nexeon MedSystems Inc.（美国）
Checkpoint Surgical, Inc.（美国）

简介目录

Product Code: SQMIG35I2162

Global Nerve Repair And Regeneration Market size was valued at USD 8.2 Billion in 2022 and is poised to grow from USD 9.2 Billion in 2023 to USD 23.05 Billion by 2031, at a CAGR of 12.17% during the forecast period (2024-2031).

The upward trajectory of the global market is fueled by the escalating prevalence of neurological disorders worldwide, including Parkinson's disease, Alzheimer's, and various Central Nervous System (CNS) disorders. This surge in afflicted individuals has spurred a heightened demand for effective treatment options. Major players in the medical sector are actively involved in bolstering their product pipelines to meet this escalating demand, channeling significant efforts into research and development endeavors to drive technological advancements aimed at enhancing the efficacy of neurological disorder treatments. These strides are poised to substantially fuel market expansion. Furthermore, the proliferation of therapeutic options for diverse CNS disorders amplifies market prospects. Notably, therapies utilizing processed nerve allografts have exhibited promising outcomes in reinstating motor and sensory nerve functions among patients grappling with upper extremity nerve impairments. A study presented at the annual meeting of the American Society for Surgery of the Hand revealed that 75% of patients treated with a specific nerve allograft witnessed motor function recovery, with 85% experiencing restored sensory nerve function. Additionally, heightened public awareness regarding neurological disorders, coupled with factors encompassing environmental influences, lifestyle choices, genetics, nutrition, and physical injuries, has cultivated a deeper understanding of these conditions. This augmented awareness has notably contributed to the escalating demand for nerve repair and regeneration solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Nerve Repair And Regeneration Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Nerve Repair And Regeneration Market Segmental Analysis

Global Nerve Repair and Regeneration Market is segmented by Type, application, and region. Based on Type, the market can be segmented into neurostimulation and neuromodulation devices, and biomaterials. Based on application, the market is segmented into peripheral nerve injury, epilepsy, Parkinson's disease, and Alzheimer's disease. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Nerve Repair And Regeneration Market

A major catalyst propelling the nerve repair and regeneration market forward is the escalating prevalence of neurological disorders worldwide, encompassing ailments like Alzheimer's disease, Parkinson's disease, and spinal cord injuries. As the frequency of these conditions rises, there's a pressing requirement for efficient treatment avenues, thus spurring an upsurge in the demand for nerve repair and regeneration therapies. This momentum is fueled by various factors including aging demographics, shifts in lifestyles, environmental impacts, and genetic susceptibilities, all underscoring the imperative for inventive solutions within the market.

Restraints in the Global Nerve Repair And Regeneration Market

A key challenge within the nerve repair and regeneration sector is the substantial expense linked to cutting-edge treatments and therapies. The advancement and adoption of innovative technologies and regenerative approaches necessitate significant investments in research, development, and production. These expenses can create significant hurdles for patients seeking access, particularly in areas with constrained healthcare resources or insufficient insurance coverage. Moreover, the reimbursement environment for nerve repair and regeneration procedures may not consistently favor affordability and accessibility for patients.

Market Trends of the Global Nerve Repair And Regeneration Market

A notable trend in the nerve repair and regeneration sector involves a heightened emphasis on regenerative medicine and stem cell therapies. Both researchers and companies are delving into the capabilities of stem cells to stimulate nerve regrowth and revive neurological functions, presenting a promising avenue for patients grappling with nerve injuries or degenerative conditions. Stem cell-based methods present the opportunity to replenish damaged or lost cells, offering hopeful prospects for innovative treatments tailored to individual needs, thereby indicating the industry's movement towards regenerative and personalized therapeutic approaches.

Executive Summary

Market Overview
Wheel of Fortune

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Parent Market Analysis

Market Overview
Market Size
Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges

Key Market Insights

Technology Analysis
Pricing Analysis
Supply Chain Analysis
Value Chain Analysis
Ecosystem of the Market
IP Analysis
Trade Analysis
Startup Analysis
Raw Material Analysis
Innovation Matrix
Pipeline Product Analysis
Macroeconomic Indicators
Top Investment Analysis
Key Success Factor
Degree of Competition

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Regulatory Landscape
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact

Global Nerve Repair and Regeneration Market by Type

Market Overview
Neurostimulation and Neuromodulation Devices
and Biomaterials

Global Nerve Repair and Regeneration Market by Application

Market Overview
Peripheral Nerve Injury
Epilepsy
Parkinson's Disease
and Alzheimer's Disease

Global Nerve Repair and Regeneration Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2021
Strategies Adopted by Key Market Players
Top Winning Strategies
- By Development
- By Company
- By Year
Recent Activities in the Market
Key Companies Market Share (%), 2021

Key Company Profiles

Medtronic (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston Scientific Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Stryker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AxoGen, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integra LifeSciences Holdings Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Baxter International Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nevro Corp (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cyberonics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Orthofix Medical Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nuvectra Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Polyganics BV (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BioTime Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Collagen Matrix, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synovis Micro Companies Alliance, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
StimGuard LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nexeon MedSystems Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Checkpoint Surgical, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments